KELSEY PETERSON: Open Payments
NPI 1639658479 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 8 payments from 8 companies in 2025. Trend: 2023 $116 · 2024 $410 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, AUSTEDO XR, AIRSUPRA, Kerendia, VRAYLAR, Qelbree, HETLIOZ, JARDIANCE.
Industry payments across NE — which companies pay providers there.
